| Literature DB >> 19936292 |
Yi Jia1, Damon R Lisch, Kazuhiro Ohtsu, Michael J Scanlon, Daniel Nettleton, Patrick S Schnable.
Abstract
Transposable elements (TEs) comprise a substantial portion of many eukaryotic genomes and are typically transcriptionally silenced. RNA-dependent RNA polymerase 2 (RDR2) is a component of the RNA-directed DNA methylation (RdDM) silencing pathway. In maize, loss of mediator of paramutation1 (mop1) encoded RDR2 function results in reactivation of transcriptionally silenced Mu transposons and a substantial reduction in the accumulation of 24 nt short-interfering RNAs (siRNAs) that recruit RNA silencing components. An RNA-seq experiment conducted on shoot apical meristems (SAMs) revealed that, as expected based on a model in which RDR2 generates 24 nt siRNAs that suppress expression, most differentially expressed DNA TEs (78%) were up-regulated in the mop1 mutant. In contrast, most differentially expressed retrotransposons (68%) were down-regulated. This striking difference suggests that distinct silencing mechanisms are applied to different silencing templates. In addition, >6,000 genes (24% of analyzed genes), including nearly 80% (286/361) of genes in chromatin modification pathways, were differentially expressed. Overall, two-thirds of differentially regulated genes were down-regulated in the mop1 mutant. This finding suggests that RDR2 plays a significant role in regulating the expression of not only transposons, but also of genes. A re-analysis of existing small RNA data identified both RDR2-sensitive and RDR2-resistant species of 24 nt siRNAs that we hypothesize may at least partially explain the complex changes in the expression of genes and transposons observed in the mop1 mutant.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19936292 PMCID: PMC2774947 DOI: 10.1371/journal.pgen.1000737
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Figure 1Comparison of SAM morphologies between mop1 mutants and non-mutants.
Safranin O/FastGreen stained image of SAMs from (A) a mop1/mop1 mutant and (B) a non-mutant sibling. See Table S1 for a quantitative analysis.
Expression patterns from diverse super-families of TEs.
| TE class | Superfamily | Total | Up | Down | Up+Down |
| I | RIL | 3 | 0 | 2 | 2 |
| RIX | 18 | 1 | 12 | 13 | |
| RLC | 153 | 44 | 62 | 106 | |
| RLG | 188 | 49 | 105 | 154 | |
| RLX | 246 | 45 | 112 | 157 | |
|
|
|
|
|
| |
| II |
| 151 | 37 | 21 | 58 |
|
| 228 | 23 | 8 | 31 | |
|
| 63 | 12 | 4 | 16 | |
|
| 9 | 0 | 0 | 0 | |
|
| 140 | 29 | 3 | 32 | |
|
| 38 | 10 | 3 | 13 | |
|
| 101 | 14 | 0 | 14 | |
|
| 67 | 11 | 0 | 11 | |
|
|
|
|
|
|
a RIL, LINE (L1) retrotransposons; RIX, unknown LINE retrotransposons; RLC, Ty1/Copia LTR retrotransposons; RLG, Ty3/Gypsy LTR retrotransposons; RLX, unknown LTR retrotransposons.
b Up, number of up-regulated sub-families/families; Down, number of down-regulated sub-families/families; sub-families for class I TEs; families for class II TEs; Up+down, total number of differentially expressed sub-families/families.
Figure 2Validation of eight differentially expressed genes via qRT–PCR.
Eight differentially expressed genes were chosen from the RdDM pathway (ago4a [Chromdb ID: AGO104], ago4b [Chromdb ID: AGO105], ago4c [Chromdb ID: AGO119], ddm1 [Chromdb ID: CHR101], met1 [Chromdb ID: DMT101]), transposons (hAT [a member of the ZM_hAT_8 sub-family; http://www.maizesequence.org]) and MULE [a member of the MULE sub-family DTM_Zm33205; http://www.maizesequence.org]) and a regulator of SAM development (liguleless3 [Gene model ID: GRMZM2G087741; http://www.maizesequence.org]) for qRT–PCR validation. Primers used for qRT–PCR are presented in 8. Fold change was presented as the relative abundance of transcript in the mop1 mutant/non-mutant. The quantitative fold changes obtained from between RNA–seq and qRT–PCR experiments were significantly correlated (Pearson correlation coefficient was 0.94, r2 = 0.88, p-value = 0.0005). A t-test of equal expression between the mutant and non-mutant using the data from four biological replications of qRT–PCR were conducted (p-value ≤0.05, *; p-value ≤0.01, **).
Differentially expressed genes in RdDM pathway.
| Chromdb ID | Gene Name | log2(FC) | FDR |
| DCL102 |
| 1.2 | 8e-06 |
| DCL104 |
| −0.5 | 1e-02 |
| AGO104 |
| −0.7 | 9e-21 |
| AGO105 |
| −1.7 | 6e-17 |
| AGO119 |
| −0.5 | 1e-06 |
| CHR127 |
| −1.3 | 1e-11 |
| DMT101 |
| −1.0 | 3e-11 |
| DMT106 |
| −0.7 | 3e-13 |
| DMT102 |
| −1.0 | 3e-40 |
| DMT105 |
| −0.7 | 4e-22 |
| SDG118 |
| −1.0 | 4e-16 |
| HDA108 |
| −0.7 | 2e-09 |
| CHR101 |
| −0.5 | 8e-04 |
| DNG101 |
| −1.0 | 4e-12 |
| DNG103 |
| −1.7 | 9e-26 |
a ID used in Chromdb (http://www.chromdb.org).
b ID used in general RdDM pathway [20].
c log2 transformation of fold change as the relative abandunce of transcripts in mutants/non-mutants. Positive value indicates the up regulation and negative value indicates down regulation.
d The false discovery rate calculated using Benjamini and Hochberg's procedure [24] for the p-value from Fisher's exact test.
Key regulators of SAM developments showing differential expression.
| Gene ID | log2(FC) | FDR | SwissProt ID | Protein Name | E-value | Ref |
| GRMZM2G104925 | −0.76 | 5.00e-04 | Q940E8 | Fasciated ear2 | 0 |
|
| GRMZM2G085113 | −0.86 | 1.62e-09 | A9XIW7 | Terminal ear1-like 2 protein | 6e-138 |
|
| GRMZM2G123140 | −0.50 | 1.05e-02 | B3GW90 | Putative HD-ZIP IV family transcription factor OCL4 | 0 |
|
| GRMZM2G087741 | 0.50 | 6.09e-06 | Q9SYT6 | Knotted class 1 homeodomain protein liguleless3 | 0 |
|
a Refer to http://www.maizesequence.org.
b log2 transformation of fold change as the relative abandunce of transcripts in mutants/non-mutants. Postive values indicate up regulation and negative values indicate down regulation.
c False discovery rate calculated using Benjamini and Hochberg's procedure [24] for the p-value from Fisher's exact test.
d Protein ID retrieved from SwissProt_Trembl database via blastp (1e-10 as cutoff).
e E-value from blastp search.